Home » Topics » Regulatory » Patents

Patents
RSS

University of British Columbia develops ERalpha antagonists

Nov. 7, 2016

Genentech and Roche describe NMDA receptor modulators

Nov. 7, 2016

Jiangsu Hengrui Medicine discloses IDO1 and/or TDO inhibitors

Nov. 7, 2016

Ruijin Hospital, Brandeis University and Xiamen University patent protein kinase inhibitors

Nov. 7, 2016

Merck KGaA presents novel activin receptor-like kinase inhibitors

Nov. 4, 2016

FORMA Therapeutics discovers new histone deacetylase inhibitors

Nov. 4, 2016

Galapagos describes novel GPR84 antagonists

Nov. 4, 2016

SIMM reports development of mGlu5 receptor modulators

Nov. 3, 2016

FORMA Therapeutics patents HDAC inhibitors

Nov. 3, 2016

AbbVie presents TNF-alpha modulators

Nov. 3, 2016

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.